Skip to content
Search

Latest Stories

No further price concessions for December, DHSC confirms

The Department of Health and Social Care (DHSC) has confirmed that the price concession announcement made on December 20, 2019 is final for the month and no further concessions will be granted.

The complete list, revealed by PSNC, is as follows:


DrugPack sizePrice Concession
Alverine 60mg capsules100£8.35
Amiloride 5mg tablets28£19.20
Cefalexin 125mg/5ml oral suspension100ml£1.95
Cefalexin 250mg/5ml oral suspension100ml£2.25
Co-careldopa 12.5mg/50mg tablets90£12.25
Co-careldopa 25mg/100mg tablets100£10.99
Colecalciferol 1,000unit capsules30£10.00
Cyclizine 50mg/1ml solution for injection ampoules5£11.98
Desmopressin 200microgram tablets30£19.85
Dexamfetamine 5mg/5ml oral solution sugar free500ml£381.63
Diclofenac sodium 75mg modified-release tablets56£9.70
Diclofenac sodium 100mg modified-release tablets28£10.40
Frovatriptan 2.5mg tablets6£11.91
Hydroxyzine 10mg tablets84£2.45
Hydroxyzine 25mg tablets28£0.97
Imipramine 25mg tablets28£2.99
Indapamide 2.5mg tablets28£2.50
Indoramin 20mg tablets60£10.64
Irbesartan 75mg tablets28£4.06
Irbesartan 150mg tablets28£7.09
Irbesartan 300mg tablets28£6.93
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£14.31
Lamotrigine 25mg dispersible tablets sugar free56£13.31
Lamotrigine 100mg dispersible tablets sugar free56£9.85
Levetiracetam 250mg tablets60£5.75
Levetiracetam 500mg tablets60£9.92
Levetiracetam 1g tablets60£10.99
Lymecycline 408mg capsules28£5.11
Meloxicam 7.5mg tablets30£3.45
Meloxicam 15mg tablets30£5.30
Memantine 10mg tablets28£4.00
Memantine 20mg tablets28£8.86
Mirtazapine 15mg tablets28£2.61
Mirtazapine 30mg tablets28£3.69
Mirtazapine 45mg tablets28£4.49
Mometasone 50micrograms/dose nasal spray140 dose£4.42
Montelukast 5mg chewable tablets sugar free28£1.86
Nefopam 30mg tablets90£19.79
Nifedipine 5mg capsules90£51.95
Nifedipine 10mg capsules90£65.63
Nifedipine 10mg modified-release tablets56£9.23
Nitrazepam 5mg tablets28£2.64
Nitrofurantoin 50mg tablets28£11.87
Nitrofurantoin 100mg tablets28£9.44
Oxytetracycline 250mg tablets28£5.35
Pizotifen 500microgram tablets28£1.80
Pizotifen 1.5mg tablets28£5.98
Propranolol 40mg tablets28£1.35
Quetiapine 25mg tablets60£2.70
Quinine sulfate 300mg tablets28£9.02
Ranitidine 150mg tablets60£4.15
Ranitidine 300mg tablets30£4.95
Rivastigmine 1.5mg capsules28£3.57
Rivastigmine 3mg capsules28£3.95
Sodium fluoride 0.05% mouthwash sugar free250ml£1.85
Tamoxifen 20mg tablets30£4.71
Tetracycline 250mg tablets28£4.79
Tizanidine 2mg tablets120£12.00
Trihexyphenidyl 2mg tablets84£9.08
Venlafaxine 37.5mg tablets56£7.18
Venlafaxine 75mg tablets56£13.97
Zolpidem 5mg tablets28£1.71

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less